Julie Klish Tibbets Alston & Bird LLP
Results 1 to 5 of 64
FDA streamlines CGMP compliance for combination products *
USA - January 24 2013
On January 22, 2013, the U.S. Food and Drug Administration (FDA) published its final rule implementing current good manufacturing practice (CGMP)…
Co-authors: Donald E. Segal, Guillermo E. Cuevas.
FDA acceptance policies on PMA and 510(k) submissions *
USA - January 14 2013
On December 31, 2012, FDA issued two guidance documents detailing the agency's approach to reviewing the completeness of medical device applications…
Co-authors: Donald E. Segal, Guillermo E. Cuevas.
United States v. Caronia – watershed decision on off-label promotion? *
USA - December 11 2012
The regulatory landscape regarding off-label drug promotion may be changing in light of the Second Circuit’s recent decision in United States v. Caronia.
Co-authors: Guillermo E. Cuevas, Marc J. Scheineson.
On the horizon – what to expect from FDA in 2013 *
USA - November 15 2012
With the reelection of President Obama, the U.S. Food and Drug Administration (FDA) is likely to continue its current high level of regulatory oversight and enforcement.
Co-authors: Guillermo E. Cuevas.
Ripe for congressional reform *
USA - November 15 2012
In response to the NECC fungal meningitis outbreak, Representative Edward Markey (D-MA) introduced new legislation to expand FDA authority over prescription drug compounders.
Co-authors: Guillermo E. Cuevas.
Co-authors of Julie Klish Tibbets
Other Alston & Bird LLP authors
- Andrea Warren,
- Brendan Krasinski,
- Bruce Sarkisian,
- Catherine Payne,
- Cathy L. Burgess,
- Edward T. Kang,
- Elizabeth Wilson Vaughan,
- Heather Byrd Asher,
- Johann Lee,
- John R. Hickman,
- John Spears,
- Mark McCarty,
- Matthew D. Justus,
- Matthew D. Richardson,
- Maureen Gorsen,
- Patrick C. DiCarlo,
- Patrick J. Flinn,
- Randall L. Allen,
- Stacy C. Clark,
- Susan E. Hurd
